149 related articles for article (PubMed ID: 35260385)
1. Risk of breast cancer with HRT depends on therapy type and duration.
Saul H; Gursul D; Cassidy S; Vinogradova Y
BMJ; 2022 Mar; 376():o485. PubMed ID: 35260385
[TBL] [Abstract][Full Text] [Related]
2. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Kuller LH
J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
[No Abstract] [Full Text] [Related]
3. Re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
Archer DF; Bush T; Nachtigall LE
J Natl Cancer Inst; 2000 Dec; 92(23):1950-2. PubMed ID: 11106695
[No Abstract] [Full Text] [Related]
4. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer and hormone-replacement therapy: the Million Women Study.
Garton M
Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
[No Abstract] [Full Text] [Related]
6. Hormone replacement therapy and breast cancer.
Stanford JL; Weiss NS
Arch Fam Med; 1996 Jun; 5(6):349-50. PubMed ID: 8640325
[No Abstract] [Full Text] [Related]
7. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
Połać I; Borowiecka M; Wilamowska A; Nowak P
Gynecol Endocrinol; 2013 Feb; 29(2):165-8. PubMed ID: 23116237
[TBL] [Abstract][Full Text] [Related]
8. The effect of estrogen plus progestin hormone therapy on breast cancer mortality: still unresolved.
Schairer C; Brinton LA
J Natl Cancer Inst; 2013 Apr; 105(8):513-4. PubMed ID: 23543780
[No Abstract] [Full Text] [Related]
9. Increased coronary events, HERS, and HRT: any connection?
Rebar RW; Archer D
Arch Intern Med; 2001 May; 161(10):1350-1. PubMed ID: 11371266
[No Abstract] [Full Text] [Related]
10. Understanding breast density and breast cancer risk.
Peres J
J Natl Cancer Inst; 2012 Sep; 104(18):1345-6. PubMed ID: 22984197
[No Abstract] [Full Text] [Related]
11. Cancer risk in women receiving estrogen-progestin replacement therapy.
Persson I
Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
[TBL] [Abstract][Full Text] [Related]
12. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
von Schoultz B
Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
[No Abstract] [Full Text] [Related]
13. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
[TBL] [Abstract][Full Text] [Related]
14. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
Grant EC
J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
[No Abstract] [Full Text] [Related]
15. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy and breast cancer.
Prescrire Int; 2009 Apr; 18(100):66-7. PubMed ID: 19585723
[TBL] [Abstract][Full Text] [Related]
17. Oestrogens and progestins and breast cancer risk in post-menopausal women.
La Vecchia C
Pharmacol Res; 1995 Dec; 32(6):323-4. PubMed ID: 8736479
[No Abstract] [Full Text] [Related]
18. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
19. Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation.
Corrao G; Zambon A; Conti V; Nicotra F; La Vecchia C; Fornari C; Cesana G; Contiero P; Tagliabue G; Nappi RE; Merlino L
Ann Oncol; 2008 Jan; 19(1):150-5. PubMed ID: 17785762
[TBL] [Abstract][Full Text] [Related]
20. Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
Shapiro S; deVilliers TJ; Pines A; Sturdee DW; Archer DF; Baber RJ; Panay N; Farmer RD; Stevenson JC; Mueck AO; Burger HG; Gompel A
J Natl Cancer Inst; 2014 Feb; 106(2):djt372. PubMed ID: 24363446
[No Abstract] [Full Text] [Related]
[Next] [New Search]
